![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Merck to Acquire SmartCells, Inc
Merck & Co., Inc., and SmartCells, Inc., announced that they have entered into a definitive...
Cold Chain Smart Solutions Conference
While cold chain management is becoming an evermore important part of a pharmaceutical firm’s business...
Ranbaxy Launches Donepezil 5MG and 10MG Tablets
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL...
Quintiles and London Genetics Alliance T0 Enchance Drug Discovery and Development
Quintiles, the world’s leading bio pharmaceutical services company, and London Genetics, an expert in the...
Vertex Completes New Drug Application for Telaprevir for Hepatitis C
Vertex Pharmaceuticals Incorporated announced that it has completed the submission of a New Drug Application...
Sun Pharma announces FDA tentative approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for...
Lilly and Acrux Receive FDA Approval for Axiron Topical Solution CIII
Eli Lilly and Company and Acrux announced that the U.S. FDA has approved Axiron topical...
VYTORIN the cholesterol-lowering medicine from Merck
In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck (known as MSD...
Antares Pharma Announces Next Generation of Auto-Injector Design
Antares Pharma, Inc., a leader in self-injection drug delivery technology, announced the latest advancement in...
Pfizer Announces Positive Phase 3 Trial Results for Axitinib
Pfizer Inc.announced that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib...